XBiotech (XBIT)
Develops human-derived monoclonal antibodies through integrated Austin research, clinical development and manufacturing.
$2.20
At close−0.02 (−0.90%)
Something off on this page? Send us feedback.
EPSReportedEstimate
Nov '24Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26
Reported−$0.16−$0.34−$0.36−$0.06−$0.20−$0.88−$0.18−$0.22
Estimate—————$0.04$0.03$0.03
Surprise—————−2,300.0%−700.0%−833.3%
RevenueReportedEstimate
Nov '24Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26
Reported————————
Estimate—————$7.0M$7.0M$7.0M
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Aug 2026 | $0.03 | −$0.22 | −833.3% |
| May 2026 | $0.03 | −$0.18 | −700.0% |
| Mar 2026 | $0.04 | −$0.88 | −2,300.0% |
| Nov 2025 | — | −$0.20 | — |
The latest year is open to everyone — the 42 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Oct 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| May 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | $0.03 | −$0.22 | −833.3% | $7.0M | — | — | −5.3% |
| May 14, 2026 | $0.03 | −$0.18 | −700.0% | $7.0M | — | — | −1.6% |
| Mar 13, 2026 | $0.04 | −$0.88 | −2,300.0% | $7.0M | — | — | −0.4% |
| Nov 12, 2025 | — | −$0.20 | — | — | — | — | −4.3% |
The latest year is open to everyone — the 42 quarters behind it read with an account. Sign in | |||||||
| Aug 13, 2025 | |||||||
| May 14, 2025 | |||||||
| Mar 18, 2025 | |||||||
| Nov 13, 2024 | |||||||
| Aug 12, 2024 | |||||||
| May 10, 2024 | |||||||
| Mar 15, 2024 | |||||||
| Nov 9, 2023 | |||||||
| Aug 11, 2023 | |||||||
| May 10, 2023 | |||||||
| Mar 15, 2023 | |||||||
| Nov 9, 2022 | |||||||
| Aug 10, 2022 | |||||||
| May 10, 2022 | |||||||
| Mar 15, 2022 | |||||||
| Nov 9, 2021 | |||||||
| Aug 9, 2021 | |||||||
| May 10, 2021 | |||||||
| Mar 16, 2021 | |||||||
| Nov 9, 2020 | |||||||
| Aug 10, 2020 | |||||||
| May 11, 2020 | |||||||
| Mar 16, 2020 | |||||||
| Nov 12, 2019 | |||||||
| Aug 9, 2019 | |||||||
| May 9, 2019 | |||||||
| Mar 13, 2019 | |||||||
| Oct 31, 2018 | |||||||
| Aug 9, 2018 | |||||||
| May 8, 2018 | |||||||
| Mar 16, 2018 | |||||||
| Nov 9, 2017 | |||||||
| Aug 8, 2017 | |||||||
| May 10, 2017 | |||||||
| Mar 16, 2017 | |||||||
| Nov 14, 2016 | |||||||
| Aug 12, 2016 | |||||||
| May 18, 2016 | |||||||
| Mar 30, 2016 | |||||||
| Nov 13, 2015 | |||||||
| Aug 14, 2015 | |||||||
| May 27, 2015 | |||||||